These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 34693960)
1. A triple-stimulus responsive melanin-based nanoplatform with an aggregation-induced emission-active photosensitiser for imaging-guided targeted synergistic phototherapy/hypoxia-activated chemotherapy. Yu J; Zhang X; Pei Z; Shuai Q J Mater Chem B; 2021 Nov; 9(44):9142-9152. PubMed ID: 34693960 [TBL] [Abstract][Full Text] [Related]
2. Near-infrared photoactivatable three-in-one nanoagents to aggravate hypoxia and enable amplified photo-chemotherapy. Yu N; Zhou J; Xu H; Wang F; Wang X; Tang L; Li J; Wang X; Lu X Biomater Adv; 2024 Oct; 163():213962. PubMed ID: 39032435 [TBL] [Abstract][Full Text] [Related]
3. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy. Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784 [TBL] [Abstract][Full Text] [Related]
4. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer. Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921 [TBL] [Abstract][Full Text] [Related]
5. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy. Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102 [TBL] [Abstract][Full Text] [Related]
6. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles. Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027 [TBL] [Abstract][Full Text] [Related]
7. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy. Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718 [TBL] [Abstract][Full Text] [Related]
8. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy. Zhang G; Wang W; Zou H; Wei Z; Song C; Ran J; Cao Z; Cai Y; Han W J Mater Chem B; 2021 Jul; 9(26):5318-5328. PubMed ID: 34231629 [TBL] [Abstract][Full Text] [Related]
9. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor. Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765 [TBL] [Abstract][Full Text] [Related]
10. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer. Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271 [TBL] [Abstract][Full Text] [Related]
11. A multifunctional nano-delivery system enhances the chemo- Zhao R; Ning X; Wang M; Yu A; Wang Y J Mater Chem B; 2021 Nov; 9(44):9174-9182. PubMed ID: 34698329 [TBL] [Abstract][Full Text] [Related]
12. Optimized Combination of Photodynamic Therapy and Chemotherapy Using Gelatin Nanoparticles Containing Tirapazamine and Pheophorbide a. Lee D; Jang SY; Kwon S; Lee Y; Park E; Koo H ACS Appl Mater Interfaces; 2021 Mar; 13(9):10812-10821. PubMed ID: 33624503 [TBL] [Abstract][Full Text] [Related]
13. H Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965 [TBL] [Abstract][Full Text] [Related]
14. Enhanced photo-hypoxia-activated combination therapy traced by AIE photosensitizer and targeted by hyaluronic acid: Disulphide bond interference of detoxification barrier. Ouyang F; Zhang X; Zhang L; Liu Y; Shuai Q J Photochem Photobiol B; 2022 Sep; 234():112535. PubMed ID: 35930948 [TBL] [Abstract][Full Text] [Related]
15. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation. Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209 [TBL] [Abstract][Full Text] [Related]
16. Pd@Au Bimetallic Nanoplates Decorated Mesoporous MnO Zhang Y; Lv F; Cheng Y; Yuan Z; Yang F; Liu C; Cao Y; Zhang K; Lu H; Zada S; Guo S; Dong H; Zhang X Adv Healthc Mater; 2020 Jan; 9(2):e1901528. PubMed ID: 31820854 [TBL] [Abstract][Full Text] [Related]
17. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy. Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794 [TBL] [Abstract][Full Text] [Related]
18. ZnS@ZIF-8 core-shell nanoparticles incorporated with ICG and TPZ to enable H Fang C; Cen D; Wang Y; Wu Y; Cai X; Li X; Han G Theranostics; 2020; 10(17):7671-7682. PubMed ID: 32685012 [TBL] [Abstract][Full Text] [Related]
19. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles. Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252 [TBL] [Abstract][Full Text] [Related]
20. Ce6-Modified Carbon Dots for Multimodal-Imaging-Guided and Single-NIR-Laser-Triggered Photothermal/Photodynamic Synergistic Cancer Therapy by Reduced Irradiation Power. Sun S; Chen J; Jiang K; Tang Z; Wang Y; Li Z; Liu C; Wu A; Lin H ACS Appl Mater Interfaces; 2019 Feb; 11(6):5791-5803. PubMed ID: 30648846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]